Skip to main content
AHCO logo

AHCO · AdaptHealth Corp.

Track AHCO — free
$5.81 +0.11 (+1.93%) At close · Aug 14
Market Cap
$792.16M
Shares
136.34M

AdaptHealth Corp. Earnings Call Transcripts

Every quarterly earnings call for AdaptHealth Corp. (AHCO) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Conference
Investor event
2026-08-07
AdaptHealth Corporation To Participate in Upcoming Investor Conferences
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-04
AdaptHealth Corp. Q2 FY2026 Earnings Call
Revenue
$740.31M
▲ 12.7% YoY
Diluted EPS
$-0.99
▼ 1090% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-05
AdaptHealth Corp. Q1 FY2026 Earnings Call
Revenue
$819.80M
▲ 5.4% YoY
Diluted EPS
$-0.12
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
AdaptHealth Corp. Q4 FY2025 Earnings Call
Confident tone Capitated contract execution Patient census and new starts Diabetes health
Revenue
$989.56M*
▲ 15.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
AdaptHealth Corp. Q3 FY2025 Earnings Call
Confident tone 2026 outlook and guidance Capitated partnerships Profitability and adjusted EBITDA
Revenue
$820.31M
▲ 1.8% YoY
Diluted EPS
$0.16
▲ 6.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
AdaptHealth Corp. Q2 FY2025 Earnings Call
Confident tone New capitated national contract Balance sheet and deleveraging CMS competitive bidding proposed rule
Revenue
$657.10M
▼ 18.5% YoY
Diluted EPS
$0.10
▼ 23.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-06
AdaptHealth Corp. Q1 FY2025 Earnings Call
Positive tone Q1 financial results vs. guidance Tariff and trade policy exposure Organic growth strategy and market opportunity
Revenue
$777.88M
▼ 1.8% YoY
Diluted EPS
$-0.05
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
AdaptHealth Corp. Q4 FY2024 Earnings Call
Positive tone Q4 2024 results vs guidance Diabetes Health turnaround Capitated arrangements and Humana contract
Revenue
$856.64M*
▼ 0.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-05
AdaptHealth Corp. Q3 FY2024 Earnings Call
Positive tone Sleep Growth Diabetes Turnaround CGM and Pharmacy Channel Pressure
Revenue
$805.86M
▲ 0.2% YoY
Diluted EPS
$0.15
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
AdaptHealth Corp. Q2 FY2024 Earnings Call
Positive tone Organic Growth Across Sleep, Respiratory, and Diabetes Respiratory Market Share Gains and Humana Contract Diabetes Channel Strategy and Pharmacy Distribution
Revenue
$805.98M
▲ 1.6% YoY
Diluted EPS
$0.13
▲ 44.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
AdaptHealth Corp. Q1 FY2024 Earnings Call
Confident tone Humana contract Capitated/revenue reporting Diabetes business turnaround
Revenue
$792.50M
▲ 6.4% YoY
Diluted EPS
$-0.02
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
AdaptHealth Corp. Q4 FY2023 Earnings Call
Confident tone Sleep product line performance Diabetes business Leverage and debt reduction
Revenue
$858.23M*
▲ 10% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-07
AdaptHealth Corp. Q3 FY2023 Earnings Call
Revenue
$804.03M
▲ 6.3% YoY
Diluted EPS
$-3.43
▼ 3218.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
AdaptHealth Corp. Q2 FY2023 Earnings Call
Revenue
$793.29M
▲ 9% YoY
Diluted EPS
$0.09
▲ 0% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
AdaptHealth Corp. Q1 FY2023 Earnings Call
Revenue
$744.63M
▲ 5.4% YoY
Diluted EPS
$-0.06
▼ 175% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-01-11
AdaptHealth Corp. Q4 FY2022 Earnings Call
Revenue
$780.28M*
▲ 11.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
AdaptHealth Corp. Q3 FY2022 Earnings Call
Revenue
$756.50M
▲ 15.8% YoY
Diluted EPS
$0.11
▼ 45% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
AdaptHealth Corp. Q2 FY2022 Earnings Call
Revenue
$727.61M
▲ 17.9% YoY
Diluted EPS
$0.09
▼ 25% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
AdaptHealth Corp. Q1 FY2022 Earnings Call
Revenue
$706.20M
▲ 46.5% YoY
Diluted EPS
$0.08
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
AdaptHealth Corp. Q4 FY2021 Earnings Call
Revenue
$702.11M*
▲ 101.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
AdaptHealth Corp. Q3 FY2021 Earnings Call
Revenue
$653.29M
▲ 129.7% YoY
Diluted EPS
$0.20
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
AdaptHealth Corp. Q2 FY2021 Earnings Call
Revenue
$617.02M
▲ 165.8% YoY
Diluted EPS
$0.12
▲ 50% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
AdaptHealth Corp. Q1 FY2021 Earnings Call
Revenue
$482.12M
▲ 151.8% YoY
Diluted EPS
$-0.08
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-04
AdaptHealth Corp. Q4 FY2020 Earnings Call
Revenue
$348.43M*
▲ 133% YoY
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-04
AdaptHealth Corp. Q3 FY2020 Earnings Call
Revenue
$284.40M
▲ 108.4% YoY
Diluted EPS
$-0.89
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-04
AdaptHealth Corp. Q2 FY2020 Earnings Call
Revenue
$232.12M
▲ 87% YoY
Diluted EPS
$0.08
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
AdaptHealth Corp. Q1 FY2020 Earnings Call
Revenue
$191.44M
▲ 60.2% YoY
Diluted EPS
$-0.82
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-25
AdaptHealth Corp. Q4 FY2019 Earnings Call
Revenue
$149.54M*
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–28 of 28 earnings calls
Key facts CIK 1725255 CUSIP 00653Q102 13F (30d) 219 filings 217 filers Visit website Investor relations